REGENERON PHARMACEUTICALS (REGN:NASDAQ)
$776.79 2.68 (0.3462%)
Analysed REGENERON PHARMACEUTICALS (REGN:NASDAQ) News Sources
Regeneron Pharmaceuticals Stock: Is REGN Outperforming the Healthcare Sector?
02-09-2026
barchart.com
2026 Complement Inhibitors Market Analysis Report (2nd Edition) Featuring Amgen, CSL Behring, Innovent Biologics, Novartis, Regeneron, Roche, Sanofi, Takeda, UCB
02-09-2026
yahoo.com
Vertex vs. Regeneron: Which Biotech Giant Is the Better Buy Right Now?
04-09-2026
fool.com
3 Reasons to Avoid REGN and 1 Stock to Buy Instead
08-09-2026
yahoo.com
Here’s Why The Fund Sold Regeneron Pharmaceuticals (REGN)
09-09-2026
yahoo.com
Regeneron Eyes 2026 Catalysts as EYLEA HD and DUPIXENT Drive Growth
12-09-2026
marketbeat.com
Regeneron Highlights Dupixent Growth, Cemdisiran Catalysts and EYLEA HD Momentum
15-09-2026
marketbeat.com
Regeneron Pharmaceuticals (REGN) Could Be 5% Undervalued Following Trial Lawsuit News
15-09-2026
yahoo.com
Novo Nordisk vs. Regeneron Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?
15-09-2026
fool.com
Will Fianlimab-Libtayo Trial Misstatement Lawsuits Change Regeneron Pharmaceuticals' (REGN) Pipeline-Driven Narrative?
15-09-2026
yahoo.com
What is the current price of REGENERON PHARMACEUTICALS (REGN:NASDAQ)?
The current price of REGENERON PHARMACEUTICALS (REGN:NASDAQ) is $776.79.
REGENERON PHARMACEUTICALS (REGN:NASDAQ) absolute price change since previous trading day?
The absolute price change of REGENERON PHARMACEUTICALS (REGN:NASDAQ) since the previous trading day is $2.68.
REGENERON PHARMACEUTICALS (REGN:NASDAQ) percentage price change since previous trading day?
The percentage price change of REGENERON PHARMACEUTICALS (REGN:NASDAQ) since the previous trading day is 0.3462%.
What is the most recent average sentiment score for REGENERON PHARMACEUTICALS (REGN:NASDAQ)?
The most recent average sentiment score for REGENERON PHARMACEUTICALS (REGN:NASDAQ) is 63 out of 100.
What is the most recent average sentiment for REGENERON PHARMACEUTICALS (REGN:NASDAQ)?
The most recent sentiment for REGENERON PHARMACEUTICALS (REGN:NASDAQ) is .
SEC-8K** Filing Available For REGENERON PHARMACEUTICALS (REGN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.